The largest database of trusted experimental protocols

Sm2 bio beads

Manufactured by Bio-Rad
Sourced in United States, United Kingdom, Germany

SM2 Bio-Beads are porous polymeric beads designed for a variety of chromatographic applications. They feature a high surface area and controlled pore size, making them suitable for size-exclusion, adsorption, and other separation techniques.

Automatically generated - may contain errors

67 protocols using sm2 bio beads

1

Proteoliposome Assay for Ion Channel Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lipid mixtures, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE) and 1-palmitoyl-2-oleoyl-snglycero-3-phospho-(1'-rac-glycerol) (POPG) at a 3:1 ratio (w/w) or POPE, POPG and PI(4,5)P2 at a 3:1:0.1 ratio were dried under an argon stream, and placed in a vacuum chamber overnight. Dried lipids were suspended by sonication in buffer containing 20 mM Tris pH 8 and 160 mM KCl. DDM was added and mixed with the lipid suspension for 1 hour at room temperature. The final DDM concentration was 10 mM and the lipid concentration 10 mg/ml. Purified channel complex was added to the lipid/DDM mixture at a protein-to-lipid ratio of 1:250 (w/w). After 30-min incubation at room temperature, SM2 biobeads (Bio-Rad) were added to remove DDM by incubating the mixture at 4 °C overni ght.
Proteoliposome vesicles were collected, briefly sonicated and diluted 25 times in buffer containing 20 mM Tris pH 8 and 160 mM NaCl and prior to the assay. 6 μl vesicles was mixed with 6 μl ACMA solution (7.5 μM) and 12 μl buffer (20 mM Tris pH 8 and 160 mM NaCl). Fluorescence was recorded every 5 seconds (λEX = 410 nm, λEM = 490 nm) using a plate reader (Tecan Infinite M1000). After the ACMA fluorescence stabilized, K+ flux was initiated by addition of 6 μl CCCP (40 μM). At the end of the assay, 2 μM valinomycin was added to release K+ from all vesicles and yield a minimum baseline fluorescence.
+ Open protocol
+ Expand
2

Reconstitution of KCNE1 in POPC:POPG Liposomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
A POPC:POPG lipid bilayer was used to mimic phospholipids typically found in mammalian membranes[9 (link), 12 (link), 15 (link)–17 (link), 25 (link), 26 (link)]. POPC and POPG powdered lipids (Avanti, Alabaster, AL) were dissolved to a total final concentration of 5 mM (9/1 POPC/POPG molar ratio) in 5 mM HEPES and 0.5% DM (n-Dodecyl-β-D-maltoside) (pH 7.0) by repeating at least 10 freeze/thaw cycles until the solutions were clear[12 (link)]. SM2 Bio Beads (Bio-Rad) were washed with 8× 20 mL volumes of methanol followed by 8× 20 mL volumes of water prior to use. Samples were reconstituted by mixing 1 mL of the lipid slurry with 157 μg of KCNE1 protein in 0.2% SDS (500/1 lipid/protein molar ratio) and repeating 2 freeze/thaw cycles. The lipid/protein mixture was then added to 300 mg of wet Bio Beads and nutated at room temperature for 2 hours. Previous studies showed that this amount of Bio Beads effectively removes all detergent and forms MLVs[27 (link)]. The resulting sample was centrifuged at 2,000 g for 5 minutes to remove excess Bio Beads. The supernatant was concentrated by ultracentrifugation at 300,000 g for 30 minutes. The proteoliposome pellet was thoroughly resuspended in 50 μL of 100 mM NaH2PO4 (pH 7.2) and immediately used in spectroscopic studies.
+ Open protocol
+ Expand
3

Preparation of Influenza Virosomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
Influenza virosomes were prepared as follows. In short: per ml of final formulation, 8 mg of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine; Merck, Darmstadt, Germany) and 1 mg of OPPE were dissolved in 100 mM OEG in PBS pH 7.4 (52.7 mM phosphate, 82 mM NaCl). Inactivated influenza A/Brisbane/59/2007 H1N1 virus was mixed with PBS and centrifuged at 100.000xg for 1h at 18°C. The pellet of inactivated influenza virus was resuspended with 100 mM OEG-PBS pH 7.4 for 10 min followed by sonication for 1 min at 30°C. This mixture was centrifuged at 100.000xg for 1h at 18°C to pellet down the nucleocapsid complex. The supernatant containing the solubilized influenza membrane proteins and lipids was used for virosome formulation and mixed with phospholipids at a concentration of 0.2 mg/ml hemagglutinin (HA). Virosome formation took place after removal of OEG detergent using 0.375 g per ml of formulation of SM2 Bio-Beads (BioRad) twice for 1h and once for 30 min at room temperature whilst mixing at 100 rpm. Fluorescent virosomes were obtained by adding Atto647-PE as indicated prior to detergent removal to enable peptide incorporation. Liposomes were prepared similarly by leaving out the influenza virus component but following the same procedure. At the end of the process virosomes and liposomes were sterile filtered on 0.22 μm units (Millex-GP; Merck Millipore).
+ Open protocol
+ Expand
4

Incorporation of AHA2 into Liposomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
To facilitate the insertion of AHA2 into liposomes, preformed liposomes (4–5 mM) were solubilized by an amount of OG that was just sufficient to result in a half-maximal scattering change at 600 nm (‘Turning Point’). Purified AHA2 (12.5 μg) was added at a protein-to-lipid ratio of 1:60 (w/w). The protein/lipid/detergent mixture was subjected to gel filtration (Sephadex G-50 Fine, 3 mL packed in 2 mL disposable syringes) by centrifugation (180× g, 8 min). The eluate was incubated for 60 min at room temperature with 50 mg of prewashed SM-2 Bio-Beads (Bio-Rad Laboratories, Hercules, CA, USA) under end-over-end rotation to ensure detergent removal.
+ Open protocol
+ Expand
5

Reconstitution of TmrAB Nanodiscs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Purified TmrAB and MSP1D1 were mixed with bovine brain lipid extract (Sigma-Aldrich) solubilized in 20 mM of β-DDM at a TmrAB:MSP1D1:lipid molar ratio of 1:7.5:100 in SEC buffer without detergent. After incubation at RT for 30 min, SM-2 Bio-beads™ (Bio-Rad) were added in two consecutive incubation steps to remove the detergent (1 h, overnight). TmrAB-containing nanodiscs were separated from empty discs by SEC (Superdex™ 200 Increase 3.2/300, GE Healthcare) in SEC buffer without detergent and concentrated to 5 mg/ml at 1,500 x g using Amicon® Ultra-0.5 ml centrifugal filters with a 50 kDa cut-off (Millipore). For EM, a 1.25-fold molar excess of Nb9F10 was added and incubated for 15 min on ice. TmrAB-Nb-complexes were separated from unbound Nb by SEC (KW404-4F, Shodex) in SEC buffer without detergent.
+ Open protocol
+ Expand
6

Quantitative Analysis of Peptide Uptake by Liposomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
TmrAB-containing liposomes (0.4 µM) were incubated with C4ATTO655 peptides (1 µM), ATP or ADP (3 mM each), MgCl2 (5 mM), and CPFs (1 µM) for 5 min at 45°C. Transport reactions were stopped by adding EDTA (10 mM). Samples were diluted to a final TmrAB concentration of 20 nM with transport buffer (20 mM HEPES-NaOH pH 7.5, 150 mM NaCl, 5% [v/v] glycerol) and analyzed by flow cytometry (FACSCelesta). For regression analysis, liposomes were loaded with increasing amounts of peptides to convert the fluorescence intensities into the number of peptides per liposome (Stefan et al., 2020 (link)). For this, liposomes were destabilized by adding Triton X-100 while increasing the C4ATTO655 concentration. Equal amounts of carboxyfluorescein (Sigma-Aldrich) served as loading control. Detergent was removed by adding SM-2 Bio-beads (Bio-Rad) as detailed above. Liposomes were harvested for 30 min at 270,000 g and washed three times by centrifugation. Generally, 20,000–100,000 proteoliposomes were selected according to sideward and forward scatter areas. Single events were selected based on the height of forward scatter plotted against the area of forward scatter. Mean fluorescence intensities of fluorescein and ATTO655 were calculated using FlowJo 10.6.1 software. Data represent mean ± SD from three experiments.
+ Open protocol
+ Expand
7

Reconstitution of OpuA in Nanodiscs

Check if the same lab product or an alternative is used in the 5 most similar protocols
For reconstitution in nanodiscs, different OpuA/MSP/lipid ratios were tested. For optimal conditions, 8.6 μM purified OpuA was mixed with 86 μM purified MSP1D1 scaffold protein and 4.3 mM lipids (with a composition of 50% DOPE, 12% DOPC, and 38% DOPG) in 75 mM potassium phosphate (pH 7.0) with 7% (v/v) glycerol and 12 mM DDM to a total volume of 700 μl. After nutating the mixture for an hour at 4°C, 500 mg of SM-2 Bio-Beads (Bio-Rad) was added to adsorb the detergent. The mixture was then allowed to incubate overnight. In the morning, the supernatant was separated from the Bio-Beads and the OpuA nanodiscs were purified by size exclusion chromatography using a Superdex 200 increase 10/300 GL column in 50 mM potassium phosphate, 200 mM KCl, or 20 mM K-Hepes (pH 7.0) plus 300 mM KCl.
+ Open protocol
+ Expand
8

Preparation of DSPE-PEG-DBCO Liposomes

Check if the same lab product or an alternative is used in the 5 most similar protocols
1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[dibenzocyclooctyl(polyethylene glycol)-2000] (ammonium salt; DSPE-PEG2000-DBCO (#880229P) and 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC; #850345) were from Avanti Polar Lipids, Inc, Alabaster, AL. Azido-dPEG4-NHS ester (#10501) and doxorubicin HCl were from Quanta BioDesign, Ltd., Plain City, OH. Bromoacetamido-PEG5-azide (BP-21097) and DSPE-PEG4-NHS ester (BP-22288) were from BroadPharm, Inc., San Diego. SM-2 Biobeads (#1523920) were from BioRad, Hercules, CA. DOTA-NHS (B280) and azido-monoamide-DOTA (B-288) were from Macrocylics, Inc., Plano TX. Sodium cholate (C6445) and tris-(2-carboxyethyl)phosphine (TCEP; C4706). CaptureSelect FcXL resin was from Thermo Fisher Scientific, Waltham, MA. IdeS proteolytic enzyme (FabRICATOR® FragIT MidiSpin kit) was from Genovis AB, Lund, Sweden). Membrane scaffold protein 1D1 (MSP1D1) was produced by Sligar et al.18 (link). Humanized anti-CEA hT84.66-M5A (M5A) was produced by Yazaki et al.25 (link).
+ Open protocol
+ Expand
9

Proteoliposome Preparation and Characterization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Proteoliposomes were prepared according to published protocols [3 (link)]. Briefly, 50 mg of phosphatidylcholine (Sigma) or phosphatidylcholine, phosphatidylethanolamine and cardiolipin (3:3:1 ratio) (Avanti) mixture was dissolved in 1 mL of chloroform. A thin lipid film was formed on a glass surface by evaporating the chloroform. Liposomes were formed by the reconstitution of the lipid in rehydration buffer containing 250 mM KCl, 5 mM HEPES, and 0.1 mM EDTA. Then, 20 μg of recombinant c-subunit protein was added to 100 μL of the liposome mixture (∼2 mg of lipids, final), and the samples were vortexed twice. For recording, proteoliposomes were dehydrated in a recording chamber and rehydrated in a recording solution (120 mM KCl, 8 mM NaCl, 0.5 mM EGTA, 10 mM HEPES (pH 7.3)) in the presence of SM2 Bio-Beads (Bio-rad) to remove the detergent (2 h, room temperature or overnight at 4 °C). The presence of the recombinant c-subunit in the liposomes was confirmed by immunohistochemistry using anti-Myc mouse monoclonal (AlexaFluor 488 conjugate) antibody (Cell Signaling), according to published methods [3 (link)].
+ Open protocol
+ Expand
10

PI-PLC–based Scramblase Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the PI-PLC–based scramblase assay, a previously reported one-pot method was used to make liposomes and proteoliposomes (27 (link), 36 (link)) using a mixture of lipids, including egg PC and brain PS at a molar ratio of 9:1. Briefly, 8.2 μmol egg PC, 0.92 μmol brain PS, and a trace amount of [3H]PI (∼25,000 cpm), [3H]GlcN-PI (∼12,000 cpm), or [3H]GlcNAc-PI (∼12,000 cpm) were combined in a glass screw-cap tube, dried under a stream of N2 gas, and solubilized in 1.9 mL of buffer A (10 mM Hepes-NaOH, pH 7.4,100 mM NaCl, 1% [wt/vol] Triton X-100). The lipid solution was vortexed at moderate speed for 20 min until the solution become completely transparent. The solubilized lipids were divided into two aliquots and mixed with or without purified CLPTM1L-FH in a final volume of 1 mL buffer A, and incubated at 4 °C for 1 h with end-over-end rotation. Proteoliposomes or protein-free liposomes were generated by two rounds of treatment with a total of 300 mg of wet SM-2 Bio-Beads (Bio-Rad) for 1 mL of sample. The samples were placed in 2-mL Eppendorf tubes, and end-over-end mixed with 100 mg of Bio-beads at room temperature for 3 h. A second portion of 200 mg of Bio-beads was added and the incubation was continued at 4 °C for 16 h. Finally, the samples were transferred to 1.5-mL Eppendorf tubes without disturbing the Bio-beads and used immediately for scramblase assays.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!